Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-14-006903
Filing Date
2014-04-07
Accepted
2014-04-09 17:01:30
Documents
1
Effectiveness Date
2014-04-07

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-14-006903.paper CERTNAS 294
  Scanned paper document scanned.pdf   39922
  Complete submission text file 9999999997-14-006903.txt   1497
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-36332 | Film No.: 14005964
SIC: 2834 Pharmaceutical Preparations